0 items USD 0.00Search
Your search for "delveinsight thalassemia global api manufacturers marketed phase iii drugs landscape 2016" gave back 83406 results.
The global Thalassemia and Complications Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
July 2023
Price: USD 3,480.00
The global Thalassemia and Complications Drugs market size was valued at US$ million in 2022. With growing demand in downstream market and recovery...
Catalog:
LPI
July 2023
Price: USD 3,660.00
Thalassemia is a congenital anemia, also known as thalassemia, thalassemia, thalassemia anemia. The global Thalassemia and Complications Drugs market...
Catalog:
MRRPB5
August 2023
Price: USD 2,900.00
The global Thalassemia and Complications Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the...
Catalog:
GIR
July 2023
Price: USD 4,480.00
Deferoxamine Mesylate is a medication used for the treatment of acute iron poisoning and chronic iron overload in patients who require regular blood...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Alpha thalassemia causes due to deficiency or absence of alpha globin chains results in alpha thalassemia which is asymptomatic with general...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Alpha Thalassemia market size was valued at US$ million in 2023. With growing demand in downstream market, the Alpha Thalassemia is...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Thalassemia market size was valued at US$ 2948.9 million in 2023. With growing demand in downstream market, the Thalassemia is forecast to...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Thalassemia is a general term for a group of inheritable blood disorders, in which the body produces abnormal hemoglobin, resulting in destruction of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Thalassemia is a general term for a group of inheritable blood disorders, in which the body produces abnormal hemoglobin, resulting in destruction of...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Thalassemia is a blood disorder passed down through families (inherited) in which the body makes an abnormal form or inadequate amount of hemoglobin...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Thalassemia is a blood disorder passed down through families (inherited) in which the body makes an abnormal form or inadequate amount of hemoglobin...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Thalassemia is a general term for a group of inheritable blood disorders, in which the body produces abnormal hemoglobin, resulting in destruction of...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Thalassemia is a blood disorder passed down through families (inherited) in which the body makes an abnormal form or inadequate amount of hemoglobin...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Summary Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI...
Catalog:
HYR
August 2021
Price: USD 3,370.00
